These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27414246)

  • 21. PSYCHOMETRIC HEPATIC ENCEPHALOPATHY SCORE FOR THE DIAGNOSIS OF MINIMAL HEPATIC ENCEPHALOPATHY IN ROMANIAN CIRRHOTIC PATIENTS--PARTIAL RESULTS.
    Badea MA; Prelipcean CC; Mihai C; Popa I; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):368-73. PubMed ID: 26204638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Ferrandez A; Rodrigo JM; Felipo V
    J Mol Med (Berl); 2007 Mar; 85(3):237-45. PubMed ID: 17216205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical importance and diagnostic methods of minimal hepatic encephalopathy].
    Stawicka A; Zbrzeźniak J; Świderska A; Kilisińska N; Świderska M; Jaroszewicz J; Flisiak R
    Pol Merkur Lekarski; 2016 Feb; 40(236):117-21. PubMed ID: 27000818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal hepatic encephalopathy in patients with decompensated liver cirrhosis.
    Marić D; Klasnja B; Filipović D; Brkić S; Ruzić M; Bugarski V
    Acta Clin Croat; 2011 Sep; 50(3):375-80. PubMed ID: 22384773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Helicobacter pylori Infection in Patients with Minimal Hepatic Encephalopathy.
    Schulz C; Schütte K; Reisener N; Voss J; Malfertheiner P
    J Gastrointestin Liver Dis; 2016 Jun; 25(2):191-5. PubMed ID: 27308650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
    Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance.
    Jiménez B; Montoliu C; MacIntyre DA; Serra MA; Wassel A; Jover M; Romero-Gomez M; Rodrigo JM; Pineda-Lucena A; Felipo V
    J Proteome Res; 2010 Oct; 9(10):5180-7. PubMed ID: 20690770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):27-32. PubMed ID: 20133225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A highly selective and sensitive spectrofluorimetric method for the assessment of 3-nitrotyrosine in serum using (Eu(TTA)
    Attia MS; Youssef AO; Abdel-Sattar NA; Amin MA; Alharthi S; Mohamed EH; Mahmoud SA; Abou-Omar MN
    RSC Adv; 2022 Feb; 12(8):4536-4542. PubMed ID: 35425515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis.
    Gad YZ; Zaher AA; Moussa NH; El-desoky AE; Al-Adarosy HA
    Arab J Gastroenterol; 2011 Jun; 12(2):58-61. PubMed ID: 21684474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy.
    Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S
    J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive evoked response potentials in patients with liver cirrhosis without diagnosis of minimal or overt hepatic encephalopathy. A pilot study.
    Ciecko-Michalska I; Wojcik J; Wyczesany M; Binder M; Szewczyk J; Senderecka M; Dziedzic T; Slowik A; Mach T
    J Physiol Pharmacol; 2012 Jun; 63(3):271-6. PubMed ID: 22791641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the inhibitory control task to detect minimal hepatic encephalopathy.
    Amodio P; Ridola L; Schiff S; Montagnese S; Pasquale C; Nardelli S; Pentassuglio I; Trezza M; Marzano C; Flaiban C; Angeli P; Cona G; Bisiacchi P; Gatta A; Riggio O
    Gastroenterology; 2010 Aug; 139(2):510-8, 518.e1-2. PubMed ID: 20470775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients.
    Li W; Li N; Wang R; Li Q; Wu H
    Hepatol Int; 2015 Apr; 9(2):218-23. PubMed ID: 25794550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel spectrofluorimetric method for measuring the activity of the enzyme alpha-L-fucosidase using the nano composite optical sensor samarium(III)-doxycycline complex doped in sol-gel matrix.
    Attia MS; Othman AM; Aboaly MM; Abdel-Mottaleb MS
    Anal Chem; 2010 Jul; 82(14):6230-6. PubMed ID: 20560531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacteroides in colonic mucosa-associated microbiota affects the development of minimal hepatic encephalopathy in patients with cirrhosis.
    Haraguchi M; Miuma S; Masumoto H; Ichikawa T; Kanda Y; Sasaki R; Fukushima M; Miyaaki H; Taura N; Nakao K
    Hepatol Int; 2019 Jul; 13(4):482-489. PubMed ID: 31290070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study.
    Tan HH; Lee GH; Thia KT; Ng HS; Chow WC; Lui HF
    Singapore Med J; 2009 Mar; 50(3):255-60. PubMed ID: 19352567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.